(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DATAOME TECHNOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DATAOME TECHNOLOGY

ST13

US500000087048099

Class

9, 35, 36, 38, 42, 44

Filing

87048099

Registration

6153448

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

50

Latest update

09/16/2025

Trademark type

Word

Nice classes

9, 35, 36, 38, 42, 44

Filing date

05/24/2016

Registration date

09/15/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/15/2020

Last transaction

09/16/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/01/2019

First use in commerce

11/01/2019

Drawing code

4

Owner type

99

Owner location

Heidelberg, DE

Examiner

BLANDU, FLORENTINA

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Molecular Health GmbH

Representatives

Peter T. Wakiyama PEPPER HAMILTON LLP

Technical classification

Nice Classes

Class 9Class 35Class 36Class 38Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable computer databases containing information in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology; downloadable computer databases containing medical and health information on humans; downloadable computer software for accessingorganizingindexingrankingintegratinglinkingreferencingsynthesizinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for mobile devicesfor accessingorganizingsynthesizingindexingrankingintegratinglinkingreferencinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humans

Class 35

Business consulting and research services for employers in the field of employee benefits in the nature of offering medical and health care plans to employees and their family members and domestic partners for medical and health care diagnostic and treatment support programs

Class 36

Financial administration of programs and services for payment and reimbursement of employee benefits in the nature of medical and health care diagnostic and treatment support programsfor employees and their family members and domestic partners

Class 38

Providing access to searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information and recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to searchable online databases containing medicalpharmaceuticalbiologicalclinicalmolecularsequencing and genomic informationdisease informationbiomarker information and medical or health information or records about or relating to humans and patient specific datamolecular test resultsscientific research for medical diagnostic and treatment purposes

Class 42

Scientific consulting and research services in the fields of health caremedicinelife sciencesbiotechnologypharmaceuticalsbioinformaticsgenomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; Scientific consulting and research services in the nature of retrievalintegrationcorrelationanalysis and interpretation of genomicsequencingmolecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical health information patient specific datamolecular test resultsdata from clinical studiesscientific research for purposes of scientificmedical and pharmaceutical research; designing and developing searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information and recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; providing a web site featuring non-downloadable software and algorithms for use by physiciansclinicians and other health care professionalslaboratory personnelconsultantsscientists and other researchers for conducting scientificmedical and pharmaceutical research; providing a web site featuring software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for purposes of scientificmedical and pharmaceutical research; providing onlinenon-downloadable mobile and web applications for mobile devicessmart phones and tabletsfor accessing information in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology for scientific research purposes; data collection services for scientific research purposes in the fields of genomicshealth carepharmaceuticalslife sciencesbioinformaticsbiotechnology and medicine; research services in the fields of retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing a web site featuring online non-downloadable computer software and algorithms for medical diagnostic and treatment purposes; providing a web site featuring online non-downloadable software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing a web site featuring online non-downloadable mobile applications for mobile devicessmart phones and tabletsnon-downloadable web applications accessible through the Internet all for retrieval of information in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticals and pharmaceutical safetylife sciences and biotechnology

Class 44

Medical consulting in the fields of retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studies; medical consulting services in the fields of healthmedical carebiotechnologybioinformaticslife sciencespharmaceuticals and medicine; providing medical information in the fields of healthhealthcarelife sciencesbiotechnologypharmaceuticals and pharmaceutical safetybioinformaticsgenetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols

Publications

History of USPTO decisions and trademark events.

50 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/15/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

09/15/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/11/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/09/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/22/2020

IUAF

USE AMENDMENT FILED

07/16/2020

EISU

TEAS STATEMENT OF USE RECEIVED

07/16/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/15/2020

EX5G

SOU EXTENSION 5 GRANTED

01/14/2020

EXT5

SOU EXTENSION 5 FILED

01/09/2020

EEXT

SOU TEAS EXTENSION RECEIVED

01/09/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/27/2019

EX4G

SOU EXTENSION 4 GRANTED

07/25/2019

EXT4

SOU EXTENSION 4 FILED

07/25/2019

EEXT

SOU TEAS EXTENSION RECEIVED

07/25/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/29/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/25/2019

EX3G

SOU EXTENSION 3 GRANTED

01/25/2019

EXT3

SOU EXTENSION 3 FILED

01/25/2019

EEXT

SOU TEAS EXTENSION RECEIVED

01/25/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/27/2018

EX2G

SOU EXTENSION 2 GRANTED

07/25/2018

EXT2

SOU EXTENSION 2 FILED

07/25/2018

EEXT

SOU TEAS EXTENSION RECEIVED

07/25/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/25/2018

DOCK

ASSIGNED TO EXAMINER

07/09/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/21/2018

EX1G

SOU EXTENSION 1 GRANTED

02/20/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/20/2018

NREV

NOTICE OF REVIVAL - E-MAILED

02/05/2018

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

02/05/2018

PETG

PETITION TO REVIVE-GRANTED

02/05/2018

PROA

TEAS PETITION TO REVIVE RECEIVED

02/05/2018

EXT1

SOU EXTENSION 1 FILED

01/25/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/25/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/30/2017

PUBO

PUBLISHED FOR OPPOSITION

05/30/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/10/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/26/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/24/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/04/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/04/2017

ALIE

ASSIGNED TO LIE

03/30/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/15/2017

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

09/15/2016

GPRA

PRIORITY ACTION E-MAILED

09/15/2016

CPRA

PRIORITY ACTION WRITTEN

09/15/2016

DOCK

ASSIGNED TO EXAMINER

09/08/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/01/2016

NWAP

NEW APPLICATION ENTERED

05/27/2016

Continuous trademark protection

Get notified about every new filing that threatens DATAOME TECHNOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.